Yalda S Mostofi

发表

Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.

Beth A. Fleck, M. Kiankarimi, J. Wen, 2008, Bioorganic & medicinal chemistry letters.

DUSP3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis Running title: Musumeci et al.; DUSP3, a new player in arterial thrombosis

T. Mustelin, T. Chung, E. Théâtre, 2014 .

Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.

Beth A. Fleck, M. Kiankarimi, Sarah C Hudson, 2008, Bioorganic & medicinal chemistry letters.

Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Brock T Brown, J. Millán, E. Sergienko, 2009, Journal of medicinal chemistry.

Dual-Specificity Phosphatase 3 Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis

T. Mustelin, T. Chung, E. Théâtre, 2014, Circulation.

DUSP 3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis

T. Mustelin, T. Chung, E. Théâtre, 2014 .

Background—A limitation of current antiplatelet therapies is their inability to separate thrombotic events from bleeding occurrences. A better understanding of the molecular mechanisms leading to platelet activation is important for the development of improved therapies. Recently, protein tyrosine p

T. Mustelin, T. Chung, E. Théâtre, 2015 .

The Role of PHOSPHO1 in the Initiation of Skeletal Calcification

Nicholas Michael Hedrick, T. Chung, J. Rascon, 2010 .

Small-Molecule Inhibitors of Vaccinia-H1-Related Phosphatase VHR

T. Mustelin, T. Chung, E. Sergienko, 2010 .

Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.

Beth A. Fleck, M. Kiankarimi, J. Wen, 2008, Bioorganic & medicinal chemistry letters.